Rapid Molecular Testing Drives POC Diagnostics Market Growth


The global Point-of-Care Molecular Diagnostics Market
is entering a high-growth phase as healthcare systems increasingly prioritizerapid, decentralized, and clinically accurate diagnostic solutions. Valued at USD 5.8 billion in 2026, the market is projected to reach USD 15.1 billion by
2036, expanding at a robust 10.0% CAGR during the forecast period. Growth is being fueled by rising demand
for near-patient testing across respiratory infections, sexually transmitted diseases (STDs), hospital-acquired infections, oncology, and gastrointestinal disorders.


The sector is undergoing structural transformation driven by the shift from centralized laboratory workflows toward portable,
sample-to-answer molecular platforms that deliver faster clinical
decision-making. Assays and kits dominate the product segment with a 52.7% share, while Real-Time Polymerase Chain Reaction (RT-PCR) remains the core technology, accounting for 64.2% of market demand in 2026 due to its high sensitivity and
broad regulatory acceptance.


Request For Sample:
https://www.futuremarketinsights.com/reports/sample/rep-gb-14279
Rapid Molecular Testing Drives POC Diagnostics Market Growth The global Point-of-Care Molecular Diagnostics Market is entering a high-growth phase as healthcare systems increasingly prioritizerapid, decentralized, and clinically accurate diagnostic solutions. Valued at USD 5.8 billion in 2026, the market is projected to reach USD 15.1 billion by 2036, expanding at a robust 10.0% CAGR during the forecast period. Growth is being fueled by rising demand for near-patient testing across respiratory infections, sexually transmitted diseases (STDs), hospital-acquired infections, oncology, and gastrointestinal disorders. The sector is undergoing structural transformation driven by the shift from centralized laboratory workflows toward portable, sample-to-answer molecular platforms that deliver faster clinical decision-making. Assays and kits dominate the product segment with a 52.7% share, while Real-Time Polymerase Chain Reaction (RT-PCR) remains the core technology, accounting for 64.2% of market demand in 2026 due to its high sensitivity and broad regulatory acceptance. Request For Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-14279
Point-of-care Molecular Diagnostics Market - Sample | Future Market Insights
Request a Free Sample for Point-of-care Molecular Diagnostics Market
0 Комментарии 0 Поделились 0 Отзывы
Реклама
VintFint https://vintfint.com